Editorial policy
Effective 16 July 2026. This policy describes the standard DrugPair is implementing for indexable health content.
Purpose and scope
DrugPair publishes educational medication-safety information for patients and caregivers. It does not diagnose, prescribe, or replace a doctor, pharmacist, poison-control center, or emergency service.
Authorship
Every guide must identify its visible author. DrugPair Editorial Team means the publishing organization; it is not a clinical credential. Individual names and qualifications are published only after identity and permission are verified.
Sources
Editors should prefer current FDA labeling and safety communications, DailyMed, NIH and PubMed, CDC resources, professional guidelines, and official manufacturer safety information. Sources must be linked near the claims they support and listed with an access date.
AI use
AI may help turn retrieved evidence into plain language. AI output is not treated as a source, cannot grant a medical-review label, and must not replace the cited primary material. If evidence or the AI provider is unavailable, the product must not show a false successful analysis.
Dates and updates
Published and materially updated dates describe editorial changes. A medically reviewed date appears only when a verified clinician completed and documented that review. Dates are not changed solely to make content appear fresh.
Conflicts and commerce
Editorial conclusions must not change to promote a paid plan. Pricing and access limits may be explained, but commercial status does not establish clinical quality or completeness.
See also methodology, medical review, and corrections.